Board Member
Ginkgo Bioworks Holdings, Inc. (DNA)Equibles does not estimate personal net worth.
Get an email with a short summary when Ginkgo Bioworks Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get DNA alertsJason Kelly is recorded as CEO and Board Member at Ginkgo Bioworks Holdings, Inc. (DNA). The newest filing on record that lists Jason Kelly as CEO and Board Member at Ginkgo Bioworks Holdings, Inc. (DNA) is dated April 29, 2026. The proxy statement of Ginkgo Bioworks Holdings, Inc. reports total compensation of $5,709,049 for Jason Kelly in fiscal 2025, including a base salary of $250,000. Disclosed compensation is on record for 6 fiscal years. Jason Kelly has spoken on 18 earnings calls and 1 other investor event across 1 company, most recently for Ginkgo Bioworks Holdings, Inc. on November 5, 2026. Ginkgo Bioworks Holdings, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ginkgo Bioworks Holdings, Inc. includes Steven Coen (CFO), Reshma Shetty (COO and Board Member), Steven P. Coen (Chief Accounting Officer) and 7 others.
“As we always say, our mission here again goes to make biology easier to engineer. Over the last few years, we've been going through a transformation with this focus on autonomous labs, and that was really our goal in 2026.”
“We always start with our mission here, which is to make biology easier to engineer at Ginko. In 2026, our goals remain the same. We want to focus and invest to win in this new category of autonomous labs.”
“Ginkgo's mission is to make biology easier to engineer. And I mentioned this at the last earnings call, but in 2026, our focus will be on investing to win the category of autonomous labs.”
“So Q4 was really a breakout quarter for us in sort of defining and really leading in the category of autonomous labs. And so you're going to hear a lot from me about that in the future.”
“I will say I think I've been having the most fun I've had at a J.P. Morgan in the last 10 years over the last few days. We had our robotics set up the Marriott Marquis lobby and had people coming by and learning about autonomous labs.”
Start not stated–present
Last confirmed April 29, 2026
Start not stated–present
Last confirmed April 29, 2026
Biotechnology · Healthcare
CEO, Board Member
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Ginkgo Bioworks Holdings, Inc. (DNA) | Chief Executive Officer | $250,000 | $5,709,049 |
| 2024 | Ginkgo Bioworks Holdings, Inc. (DNA) | Chief Executive Officer | $250,000 | $1,231,000 |
| 2023 | Ginkgo Bioworks Holdings, Inc. (DNA) | Chief Executive Officer | $250,000 | $262,019 |
| 2022 | Ginkgo Bioworks Holdings, Inc. (DNA) | Chief Executive Officer | $250,000 | $262,500 |
| 2021 | Ginkgo Bioworks Holdings, Inc. (DNA) | Chief Executive Officer | $250,000 | $380,742,276 |
| 2020 | Ginkgo Bioworks Holdings, Inc. (DNA) | Chief Executive Officer | $250,000 | $10,533,188 |
